News

With a sweeping 10% tariff now applied to nearly all imports, excluding critical sectors such as semiconductors and ...
Most of us know someone who’s taking medicine to manage cholesterol levels, if we’re not the ones taking it ourselves. In ...
With 88 years of legacy, Chung Mei Pharmaceutical is transforming into a global leader in healthcare innovation, driven by ...
With extensive experience in manufacturing APIs, advanced intermediates and specialty chemicals, SCI Pharmtech is one of ...
The Illinois expansion will happen at the company’s headquarter campus in Abbott Park. It's also growing in Dallas.
Abbott Laboratories announced a plan to invest $500 million to expand its U.S. manufacturing footprint. The medical device maker will upgrade facilities in both Illinois and Texas to expand its ...
Sol-Gel to receive $16 million during 2025Cash runway is expected to extend into the first quarter of 2027; Company expects to have sufficient ...
I n an hour-long meeting at Eli Lilly and Company’s headquarters in Indianapolis on April 15, the pharmaceutical company’s top executives met, like they had dozens of times before, to hear the ...
Medical technology and device makers are fighting for tariff exemptions, while PPE makers are applauding the levies.
Johnson & Johnson’s Joaquin Duato is no longer the highest paid CEO in pharma. Meanwhile, just two women make the top 10.
U.S. tariffs on pharmaceuticals could eventually mean higher prices for brand-name medicines, but in the near term the costs ...
Abbott expects to spend $500 million on two facilities, located in Illinois and Texas, the company said in a statement.